“…Peptides have been widely recognized as a more selective, effective, and safe method for targeting pathogenic proteins, due to their sequence-specific binding to regions of partner molecules [Padhi et al, 2014, Buchwald et al, 2014]. They have further demonstrated targeting of both extracellular and intracellular proteins, due to their small size and enhanced permeability, with or without conjugation to cell penetrating peptide (CPP) sequences [Lindgren et al, 2000, Lozano et al, 2017, Adhikari et al, 2018]. Beyond standalone peptide binders, our group has recently fused computationally-designed peptides to effector domains, such as E3 ubiquitin ligases, to enable binding and selective intracellular degradation of pathogenic targets of interest [Chatterjee et al, 2020].…”